Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
12 p, 2.8 MB Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells / Gener, Petra (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Seras-Franzoso, Joaquin (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Callejo, Patricia González (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Andrade, Fernanda (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rafael, Diana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martínez, Francesc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montero, Sara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Arango, Diego (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sayós, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Abasolo, Ibane (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Schwartz, Simon (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
There are remarkable similarities in the description of cancer stem cells (CSCs) and cancer cells with mesenchymal phenotype. Both cell types are highly tumorigenic, resistant against common anticancer treatment, and thought to cause metastatic growth. [...]
2018 - 10.1155/2018/4516454
Stem Cells International, Vol. 2018 (october 2018)  
2.
20 p, 2.7 MB Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells / Montero, Sara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Seras-Franzoso, Joaquin (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Andrade, Fernanda (Universidade do Porto) ; Martinez-Trucharte, Francesc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vilar-Hernández, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Quesada, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Xandri Monje, Helena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Arango, Diego (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Abasolo, Ibane (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rafael, Diana (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Schwartz, Simon (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Universitat Autònoma de Barcelona
Structural maintenance of chromosomes protein 2 (SMC2) is a central component of the condensin complex involved in DNA supercoiling, an essential process for embryonic stem cell survival. SMC2 over-expression has been related with tumorigenesis and cancer malignancy and its inhibition is regarded as a potential therapeutic strategy even though no drugs are currently available. [...]
2020 - 10.3390/pharmaceutics12020185
Pharmaceutics, Vol. 12 (february 2020)  
3.
1.9 MB AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells / Rafael, Diana (Universitat Autònoma de Barcelona) ; Gener, Petra (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Andrade, Fernanda (Instituto de Salud Carlos III) ; Seras-Franzoso, Joaquin (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montero, Sara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fernández Caparrós, Yolanda (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hidalgo, Manuel (Rosenberg Clinical Cancer Center Beth Israel Deaconess Medical Center) ; Arango, Diego (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Florindo, Helena F. (Universidade de Lisboa) ; Abasolo, Ibane (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Schwartz, Simon (Instituto de Salud Carlos III) ; Videira, Mafalda (Universidade de Lisboa) ; Universitat Autònoma de Barcelona
Development of RNA interference-based therapies with appropriate therapeutic window remains a challenge for advanced cancers. Because cancer stem cells (CSC) are responsible of sustaining the metastatic spread of the disease to distal organs and the progressive gain of resistance of advanced cancers, new anticancer therapies should be validated specifically for this subpopulation of cells. [...]
2018 - 10.1080/10717544.2018.1461276
Drug Delivery, Vol. 25 (april 2018) , p. 961-972  

See also: similar author names
1 Montero, S.
11 Montero, Santiago
1 Montero, Stephanie
1 Montero, Susana
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.